Skip to main content
. 2022 Oct 31;18(11):6722–6731. doi: 10.1021/acs.jctc.2c00769

Table 2. Glyoxal VMC and DMC Total Energies (a.u.) and Excitation Energies (eV)a.

      VMC
DMC
WF # det # parm E(11Ag) E(21Ag) ΔE E(11Ag) E(21Ag) ΔE
CIPSI 3749 2908 –44.6072(2) –44.3957(2) 5.76(1) –44.6564(2) –44.4482(2) 5.67(1)
  5046 3498 –44.6127(2) –44.4004(2) 5.78(1) –44.6600(2) –44.4509(2) 5.69(1)
  7040 4500 –44.6150(2) –44.4048(2) 5.72(1) –44.6613(2) –44.4534(2) 5.66(1)
  8642 5433 –44.6181(2) –44.4098(2) 5.67(1) –44.6632(2) –44.4559(2) 5.64(1)
  10,010 6188 –44.6205(2) –44.4114(2) 5.69(1) –44.6635(2) –44.4567(2) 5.63(1)
  12,132 6269 –44.6237(2) –44.4145(2) 5.70(1) –44.6654(2) –44.4576(2) 5.66(1)
  15,349 8577 –44.6276(2) –44.4180(2) 5.70(1) –44.6670(2) –44.4600(2) 5.63(1)
TBEb 5.61
CC3/AVQZc 6.76
CC4/6-31+G*d 5.699
CC4/AVDZd 5.593
CCSDTQ/6-31+G*d 5.670
exFCI/AVDZ 5.56(11)
SAC-CI/AVDZe 5.66
CASPT2(14,12)/AVQZc 5.43
PC-NEVPT2(14,12)/AVQZc 5.52
a

The number of determinants (# det) and parameters (# parm) in each trial wave function are also presented. The CIPSI expansions are performed on a NO basis and fully reoptimized in VMC.

b

This value is “safe”, as defined in ref (12), exFCI/AVDZ + (CCSDT/AVTZ-CCSDT/AVDZ).

c

Ref (13).

d

Ref (16).

e

Ref (61), see reference for basis set details.